Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Equity (2023 - 2025)

Historic Return on Equity for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Q3 2025 value amounting to 0.33%.

  • Day One Biopharmaceuticals' Return on Equity rose 1200.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.48% for FY2024, which is 700.0% up from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported Return on Equity of 0.33% as of Q3 2025, which was up 1200.0% from 0.2% recorded in Q2 2025.
  • Over the past 5 years, Day One Biopharmaceuticals' Return on Equity peaked at 0.13% during Q2 2023, and registered a low of 0.91% during Q2 2024.
  • For the 3-year period, Day One Biopharmaceuticals' Return on Equity averaged around 0.4%, with its median value being 0.37% (2024).
  • As far as peak fluctuations go, Day One Biopharmaceuticals' Return on Equity crashed by -7900bps in 2024, and later skyrocketed by 7100bps in 2025.
  • Quarter analysis of 3 years shows Day One Biopharmaceuticals' Return on Equity stood at 0.4% in 2023, then increased by 3bps to 0.39% in 2024, then rose by 14bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q3 2025, 0.2% for Q2 2025, and 0.36% during Q1 2025.